Structural highlights
7bd7 is a 1 chain structure with sequence from Equus caballus. Full crystallographic information is available from OCA. For a guided tour on the structure components use FirstGlance.
|
| Method: | X-ray diffraction, Resolution 1.5Å |
| Ligands: | , , , , , |
| Resources: | FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT |
Function
FRIL_HORSE Stores iron in a soluble, non-toxic, readily available form. Important for iron homeostasis. Iron is taken up in the ferrous form and deposited as ferric hydroxides after oxidation. Also plays a role in delivery of iron to cells. Mediates iron uptake in capsule cells of the developing kidney (By similarity).
Publication Abstract from PubMed
Arsenoplatin-1 (AP-1), the prototype of a novel class of metallodrugs containing a PtAs(OH)2 core, was encapsulated within the apoferritin (AFt) nanocage. UV-Vis absorption spectroscopy and inductively coupled plasma-atomic emission spectroscopy measurements confirmed metallodrug encapsulation and allowed us to determine the average amount of AP-1 trapped inside the cage. The X-ray structure of AP-1-encapsulated AFt was solved at 1.50 A. Diffraction data revealed that an AP-1 fragment coordinates the side chain of a His residue. The biological activity of AP-1-loaded AFt was comparatively tested on a few representative cancer and non-cancer cell lines. Even though the presence of the cage reduces the overall cytotoxicity of AP-1, it improves its selectivity towards cancer cells.
Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity.,Ferraro G, Pratesi A, Cirri D, Imbimbo P, Maria Monti D, Messori L, Merlino A Int J Mol Sci. 2021 Feb 13;22(4). pii: ijms22041874. doi: 10.3390/ijms22041874. PMID:33668605[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ Ferraro G, Pratesi A, Cirri D, Imbimbo P, Maria Monti D, Messori L, Merlino A. Arsenoplatin-Ferritin Nanocage: Structure and Cytotoxicity. Int J Mol Sci. 2021 Feb 13;22(4):1874. PMID:33668605 doi:10.3390/ijms22041874
